Whistler Conference Centre Floorplan

Registered Attendees


Registered attendees (and speakers, organizers, etc.) will have access to the following items from their Account page:

  • Abstracts from speakers and poster sessions, including the joint meeting abstracts, available 30 days prior to the meeting (You can edit your own abstract from My Account page as well)

    NOTE: Abstract authors/submitters may choose to not have their abstract available online and in the secure mobile app until a week before the meeting.

  • Full participant list, including joint meeting participants
  • Printable Invoices and Invitation Letters
  • Scholarship Information
  • Lodging Information

Login to My Account page

Cancer Immunotherapy: Mechanistic Insights to Improve Clinical Benefit (C2)

Scientific Organizers: Padmanee Sharma, Aviv Regev, Crystal L. Mackall and Kristen Hege


March 10—14, 2019

Whistler Conference Centre, Whistler, British Columbia, Canada


Sponsored by Autolus Therapeutics, Bayer AG, BioLegend, Inc., Bristol-Myers Squibb Company, Cell Research, ImmunoGen, Inc., Incyte Corporation, Roche, Surface Oncology, TESARO, Inc., Takeda Pharmaceutical Company Limited and Tessa Therapeutics Ltd.


IT’S NOT TOO LATE TO SUBMIT YOUR ABSTRACT. Abstracts received can no longer be considered for oral short talks. Abstracts for poster display opportunities will be accepted until 6 weeks before meeting start date midnight MST.
BEWARE of booking lodging through companies unaffiliated with Keystone Symposia. Click here for more details.

Keystone Symposia is committed to maintaining a positive and respectful environment at its meetings. To this end, please review and comply with our policies.

DEADLINES:
*All deadlines end at 11:59 PM US Mountain Standard Time
Scholarship Deadline: Nov 20, 2018 [details]
Discounted Abstract Deadline: Nov 20, 2018 [details]
Abstract Deadline: Dec 5, 2018 [details]
Discounted Registration Deadline: Jan 15, 2019 [details]

If you have missed a deadline due to the US government shutdown, please contact our office.

Click here to view Cancellation Policy

Submit an Abstract Register Yourself Deadlines and Fees

Rates and Deadlines listed below are for the 2019-C2 "Cancer Immunotherapy: Mechanistic Insights to Improve Clinical Benefit" conference only.

*All deadlines end at 11:59 PM US Mountain Standard Time

Deadline Date Cost
Discounted Abstract Deadline
More details		 Before and On November 20, 2018 100.00 USD*
- 50.00 USD discount
Abstract Deadline
More details		 After November 20, 2018 until January 27, 2019 100.00 USD*
* 50.00 USD of Abstract fee deducted from your registration fee when you register for this meeting
Scholarship
More details		 November 20, 2018 n/a
Discounted NON-STUDENT Registration
More details		 Before and On January 15, 2019 945.00 USD
(includes 200.00 discount)
Regular NON-STUDENT Registration
More details		 After January 15, 2019 1145.00 USD
Discounted STUDENT Registration
More details		 Before and On January 15, 2019 720.00 USD
(includes 200.00 discount)
Regular STUDENT Registration
More details		 After January 15, 2019 920.00 USD

* Changes in payment type that result in a refund are subject to a processing fee.
* Currency exchange gains/losses are the responsibility of the registrant and the Keystone Symposia will accept no liability for money loss through bank charges, transfers or currency fluctuations.




Discounted Abstract Deadline: November 20, 2018

*All deadlines end at 11:59 PM US Mountain Standard Time

Abstract Submission Fee: 100.00 USD*
Submission by this date receives 50.00 USD discount.
*50.00 USD will be applied to Registration Fee when you register

Abstract Details: It is best to submit your abstract early. Abstract and registration spaces are limited and may fill prior to the abstract or discounted registration deadlines. Submitting an abstract does not constitute or guarantee registration.

Submitting your abstract early allows us to:
  • submit your abstract to organizers to be considered for a short talk
  • accept your abstract online
  • include your abstract on our website and in our secure mobile app
  • reserve your space at the meeting for a poster presentation.**
**Submitting an abstract does not constitute or guarantee registration.
(The Abstract Deadline: is December 5, 2018)

Global Health Travel Award Deadline:

*All deadlines end at 11:59 PM US Mountain Standard Time


Global Health Travel Award Details: You MUST complete your Global Health Travel Award appplication by the Global Health Travel Award Deadline and complete the other required steps (verify your contact information and submit a recommendation letter) to be considered for a travel award.


Click here to learn more about Global Health Travel Awards.

Scholarship Deadline: November 20, 2018

*All deadlines end at 11:59 PM US Mountain Standard Time


Scholarship Details: You MUST submit your abstract by the Scholarship Deadline and complete the other required steps (submit a scholarship application and submit a mentor letter) to be considered for a scholarship.

Click here to learn more about Scholarships.

Abstract Deadline: December 5, 2018

*All deadlines end at 11:59 PM US Mountain Standard Time


Abstract Submission Fee: 100.00 USD*
*50.00 USD will be applied to Registration Fee when you register

Details: It is best to submit your abstract early. Abstract and registration spaces are limited and may fill prior to the abstract or discounted registration deadline. Submitting an abstract does not constitute or guarantee registration.

Submitting your abstract by the Abstract Deadline allows us to:

  • submit your abstract to organizers to be considered for a short talk
  • include your abstract on our website and in our secure mobile app
  • reserve your space at the meeting for a poster presentation.**
**Submitting an abstract does not constitute or guarantee registration.
Abstracts submitted after the Abstract Deadline will NOT be considered for a short talk.

(Discounted Abstract Deadline: is November 20, 2018)

Discounted Registration Deadline: January 15, 2019

*All deadlines end at 11:59 PM US Mountain Standard Time


Registration Fee: 945.00 USD* (includes 200.00 USD discount)
Student Registration Fee: 720.00 USD* (must complete student verification form)

*Includes 50.00 USD of your abstract submission fee

After the Discounted Registration Deadline:


Registration Fee: 1145.00 USD*
Student Registration Fee: 920.00 USD* (must complete student verification form)

*Includes 50.00 USD of your abstract submission fee

Registration spaces are limited and may fill prior to discounted registration deadline.

Please be advised that some meeting participants have received calls and emails from a number of different housing services, including "Exhibitors Housing Services," “Expo Housing Services,” "Global Housing," etc. THESE COMPANIES ARE NOT AFFILIATED WITH KEYSTONE SYMPOSIA and are not authorized by Keystone Symposia to contact you. These companies may tell you that the meeting is filling, without any actual knowledge to that effect, and pressure you into giving them your credit card number to make a lodging reservation with them.

We highly recommend that you not make a reservation with these companies or any other housing service! These companies' representations to participants have been misleading. Please report any calls or correspondence you might have received to Keystone Symposia and book only through lodging links in your Keystone Symposia account, an established travel agency or directly with the hotel(s) listed on our website.
No registration fees are used to fund entertainment or alcohol at this conference

Conference Program    Print  |   View meeting in 12 hr (am/pm) time


The meeting will begin on Sunday, March 10 with registration from 16:00 to 20:00 and a welcome mixer from 18:00 to 20:00. Conference events conclude on Thursday, March 14 with a closing plenary session from 17:00 to 19:00, followed by a social hour and entertainment. We recommend return travel on Friday, March 15 in order to fully experience the meeting.

SUNDAY, MARCH 10

16:00—20:00
Arrival and Registration

Grand Foyer
18:00—20:00
Welcome Mixer
No registration fees are used to fund alcohol served at this function.

Grand Foyer

MONDAY, MARCH 11

07:00—08:00
Breakfast

Grand Foyer
08:00—09:00
Welcome and Keynote Address
Registered attendees can view abstracts starting on 02/10/2019

Sea to Sky B/C
Catherine Ju-Ying Wu, Dana-Farber Cancer Institute, USA
Driving Anti-Tumor Responses with Neoantigen Vaccines

09:00—11:15
Response and Resistance Mechanisms to Cancer Immunotherapy
Registered attendees can view abstracts starting on 02/10/2019

Sea to Sky B/C
Padmanee Sharma, University of Texas MD Anderson Cancer Center, USA
From the Clinic to the Lab: Investigating Response and Resistance Mechanisms to Immune Checkpoint Therapy

Coffee Break

Philip D. Greenberg, University of Washington, USA
Resistance Mechanisms to Engineered T Cell Therapies

Robert D. Schreiber, Washington University School of Medicine, USA
Talk Title to be Announced

Short Talk(s) Chosen from Abstracts

11:15—17:00
On Own for Lunch

11:15—13:00
Poster Setup

Sea to Sky A
13:00—22:00
Poster Viewing

Sea to Sky A
16:30—17:00
Coffee Available

Grand Foyer
17:00—19:00
Technological Advances for Dissecting Immune Responses
Registered attendees can view abstracts starting on 02/10/2019

Sea to Sky B/C
Elaine R. Mardis, Nationwide Children's Hospital, USA
Talk Title to be Announced

Michael Angelo, Stanford University, USA
Mapping the Immune Landscape in Solid Tumors using MIBI

Aviv Regev, Massachusetts Institute of Technology/Broad Institute, USA
Comprehending Anti-Tumor Immune Responses through Single-Cell Studies

Short Talk(s) Chosen from Abstracts

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Sea to Sky A
19:30—22:00
Poster Session 1

Sea to Sky A

TUESDAY, MARCH 12

07:00—08:00
Breakfast

Grand Foyer
08:00—11:00
Improving Anti-Tumor Immune Responses
Registered attendees can view abstracts starting on 02/10/2019

Sea to Sky B/C
Chris H. Takimoto, Forty Seven, Inc., USA
Enhancing Antitumor Immunity by Inhibiting CD47 Signaling: An Overview of CD47 Targeting Agents in Clinical Development

Elizabeth G. Trehu, Jounce Therapeutics, USA
Lessons Learned from Clinical Trials Targeting ICOS

Coffee Break

Thomas Gajewski, University of Chicago, USA
Considerations on Turning a Cold Tumor Hot

Speaker to be Announced

Short Talk(s) Chosen from Abstracts

11:00—17:00
On Own for Lunch

11:00—13:00
Poster Setup

Sea to Sky A
13:00—22:00
Poster Viewing

Sea to Sky A
16:30—17:00
Coffee Available

Grand Foyer
17:00—19:00
Engineering T Cells
Registered attendees can view abstracts starting on 02/10/2019

Sea to Sky B/C
Crystal L. Mackall, Stanford University, USA
Next Generation CAR T Cells

Kristen Hege, Celgene, USA
Clinical Development of BCMA CAR-T Cells in Myeloma

Carl H. June, University of Pennsylvania, USA
CAR T Cell Therapies: Lessons Learned and Next Steps

Short Talk(s) Chosen from Abstracts

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Sea to Sky A
19:30—22:00
Poster Session 2

Sea to Sky A

WEDNESDAY, MARCH 13

07:00—08:00
Breakfast

Grand Foyer
08:00—11:00
Immune Checkpoints: Basic Mechanisms and Novel Targets
Registered attendees can view abstracts starting on 02/10/2019

Sea to Sky B/C
James P. Allison, University of Texas MD Anderson Cancer Center, USA
Immune Checkpoint Therapy: Lessons Learned and Next Steps

Lisa M. Coussens, Oregon Health & Science University, USA
Evaluating Myeloid Targets to Enhance Anti-Tumor Immune Responses

Coffee Break

Willem W. Overwijk, Nektar Therapeutics, USA
Intratumoral Expansion of CD8+ T cells and Depletion of Tregs after Treatment with NKTR-214, a First-In-Class, CD122-Preferential IL-2 Pathway Agonist

Xiaoyan Michelle Zhang, Kyn Therapeutics, USA
Kynureninase and AHR Inhibition, Novel and Differentiated Approaches Targeting IDO1/TDO2/Kynurenine Pathway and Beyond

Short Talk(s) Chosen from Abstracts

11:00—17:00
On Own for Lunch

11:00—13:00
Poster Setup

Sea to Sky A
13:00—22:00
Poster Viewing

Sea to Sky A
16:30—17:00
Coffee Available

Grand Foyer
17:00—19:00
Combinatorial Immunotherapy Strategies
Registered attendees can view abstracts starting on 02/10/2019

Sea to Sky B/C
Sandra Demaria, Weill Cornell Medical College, USA
Using Precision Radiotherapy to Ignite Anti-Tumor Immunity with Immunotherapy

Juan C. Jaen, Arcus Biosciences, Inc., USA
Targeting Immune Activation via Inhibition of the Adenosine Pathway

Antoni Ribas, University of California, Los Angeles, USA
Novel Combination Therapy Strategies

Short Talk(s) Chosen from Abstracts

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Sea to Sky A
19:30—22:00
Poster Session 3

Sea to Sky A

THURSDAY, MARCH 14

07:00—08:00
Breakfast

Grand Foyer
08:00—11:00
Progress Report on Immune Monitoring and Clinical Trials
Registered attendees can view abstracts starting on 02/10/2019

Sea to Sky B/C
Robert H. Vonderheide, University of Pennsylvania, USA
A Case for Priming, not Checkpoint

Ton N. Schumacher, Netherlands Cancer Institute, Netherlands
Evaluating Tumor Antigen-Specific T Cell Responses

Coffee Break

Sumit Kumar Subudhi, MD Anderson Cancer Center, USA
Immune Checkpoint Therapies in Prostate Cancer

Speaker to be Announced

Short Talk(s) Chosen from Abstracts

11:00—17:00
On Own for Lunch

16:30—17:00
Coffee Available

Grand Foyer
17:00—18:45
The Future of Cancer Immunotherapy
Registered attendees can view abstracts starting on 02/10/2019

Sea to Sky B/C
Jennifer Ann Wargo, University of Texas MD Anderson Cancer Center, USA
Microbiome Targeting and Future Strategies to Improve Cancer Immunotherapy

Michael C. Jensen, Seattle Children's Research Institute, USA
Regulating the Next Generation of Genetically Enhanced CAR T Cells

Flavius Martin, Amgen, Inc., USA
Learnings from Bispecific T-Cell Engagers, from Bedside Back to the Bench

Short Talk Chosen from Abstracts

18:45—19:00
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)
Registered attendees can view abstracts starting on 02/10/2019

Sea to Sky B/C
19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Sea to Sky A
20:00—23:00
Entertainment
Entertainment is not subsidized by conference registration fees nor any U.S. federal government grants. Funding for this expense is provided by other revenue sources.

Sea to Sky A

FRIDAY, MARCH 15

 
Departure


*Session Chair †Invited, not yet responded.


We gratefully acknowledge support for this conference from:


Directors' Fund

These generous unrestricted gifts allow our Directors to schedule meetings in a wide variety of important areas, many of which are in the early stages of research.

Click here to view all of the donors who support the Directors' Fund.

Keystone Symposia thanks our Sponsors for generously supporting this meeting:

Autolus Therapeutics Bayer AG
BioLegend, Inc. Bristol-Myers Squibb Company
Cell Research ImmunoGen, Inc.
Incyte Corporation Roche
Surface Oncology Takeda Pharmaceutical Company Limited
TESARO, Inc. Tessa Therapeutics Ltd.

We gratefully acknowledge additional support from these exhibitors at this conference:

PeproTech, Inc. 10x Genomics
Please stop by to meet these exhibitors during the conference.

We gratefully acknowledge the generous grant for this conference provided by:


National Institutes of Health

Grant No. 1R13CA236284-01

Funding for this conference was made possible (in part) by 1R13CA236284-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

We gratefully acknowledge additional support for this conference from:

American Society of Gene & Cell Therapy (ASGCT) eLife
InSphero Inc.
 

We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:



Amgen Inc.


Arcus Biosciences, Inc.


Celgene Corporation


Forty Seven, Inc.


Jounce Therapeutics, Inc.


Kyn Therapeutics


Nektar Therapeutics

We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:


Click here to view more of these organizations

Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:


Click here to view more of these organizations

If your organization is interested in joining these entities in support of Keystone Symposia, please contact: Sarah Lavicka, Director of Development, Email: sarahl@keystonesymposia.org,
Phone:+1 970-262-2690

Click here for more information on Industry Support and Recognition Opportunities.

If you are interested in becoming an advertising/marketing in-kind partner, please contact:
Yvonne Psaila, Director, Marketing and Communications, Email: yvonnep@keystonesymposia.org,
Phone:+1 970-262-2676